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Infection by the neurotropic JHM strain of mouse hepatitis virus (JHMV) results in an acute encephalomyelitis associated with demyelination.
T cells are critical in controlling viral replication, but also contribute to central nervous system (CNS) pathogenesis. To reveal a role for innate
effectors in anti-viral immunity and neurological disease, JHMV pathogenesis was studied in mice deficient in interleukin-15 (IL-15−/−) and
natural killer (NK) cells. Clinical disease, CNS inflammation and demyelination in infected IL-15−/− mice were similar to wild-type mice. Despite
the absence of NK cells and suboptimal CD8+ T cell responses, IL-15−/− mice controlled JHMV replication as efficiently as wild-type mice.
Similar kinetics of class I and class II upregulation on microglia further suggested no role of NK cells in regulating major histocompatibility
complex (MHC) molecule expression on resident CNS cells. IL-15 and NK cells thus appear dispensable for anti-viral immunity and CNS
pathogenesis during acute JHMV infection.
© 2006 Elsevier Inc. All rights reserved.Keywords: Interleukin-15; Natural killer cells; CD8+ T cells; Coronavirus; EncephalitisIntroduction
The neurotropic JHM strain of mouse hepatitis virus
(JHMV) infects multiple cell types in the central nervous
system (CNS) and causes acute encephalomyelitis and
demyelination in rodents (Marten et al., 2001; Wang et al.,
1990). Acute inflammatory responses in the CNS involve
production of matrix metalloproteinases, pro-inflammatory
chemokines and cytokines, and recruitment of both innate and
adaptive immune cells (Bergmann et al., 2003; Glass et al.,
2002; Li et al., 2004; Marten et al., 2001; Zhou et al., 2005b).
JHMV replication is controlled by T cells, prominently CD8+ T
cells, about 2 weeks after infection (Bergmann et al., 2003;
Marten et al., 2001). Nevertheless, viral RNA and inflammatory
cells persist in the CNS long after clearance of infectious virus⁎ Corresponding author. Department of Neurosciences, Cleveland Clinic
Foundation, 9500 Euclid Avenue NC30, Cleveland, OH 44195, USA. Fax: +1
216 444 7927.
E-mail address: bergmac@ccf.org (C.C. Bergmann).
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doi:10.1016/j.virol.2006.01.027(Marten et al., 2001). Neutralizing antibodies are crucial for the
final stage of clearance of infectious virus and prevent
recrudescence of persisting virus (Lin et al., 1999; Ramakrishna
et al., 2003). A pathological hallmark of JHMV infection is
ongoing immune-mediated demyelination, similar to the human
demyelinating disease, multiple sclerosis. Although there is
little evidence for demyelination in immune-deficient severe
combined immunodeficiency (SCID) or recombination activat-
ing gene 1−/− (RAG1−/−) mice, numerous depletion and
adoptive transfer studies implicate both innate and adaptive
cell types in contributing to demyelination (Fleming et al.,
1993; Houtman et al., 1995; Marten et al., 2001; Stohlman and
Hinton, 2001). Although NK cells and γδ T cells display anti-
viral activity during CNS infection in the absence of αβT cells
(Dandekar and Perlman, 2002; Paya et al., 1989; Trifilo et al.,
2004), a protective role for these innate cells has yet to be
confirmed in a non-lymphopenic host. Similarly, although γδ T
cells can influence demyelination during JHMV infection of
immunocompromised hosts (Dandekar et al., 2005; Dandekar
and Perlman, 2002), their pathogenic contribution in the
Table 1
CNS infiltrating cells during acute JHMV infection of IL-15−/− micea
Days
p.i.b
Mice CD45hi % within CD45hic
Cells (×104) d NK1.1 F4/80 CD4 CD8
5 wt 50.0 ± 15.2 8.0 65.0 8.6 2.8
IL-15−/− 32.7 ± 5.7 NDe 68.8 9.8 1.2
7 wt 92.3 ± 6.3 4.9 49.2 16.0 21.1
IL-15−/− 92.3 ± 6.3 NDe 55.5 19.6 10.3
9 wt 119.0 ± 26.9 2.1 34.3 25.5 29.1
IL-15−/− 92.3 ± 6.3 NDe 36.6 44.9 16.5
14 wt 45.1 ± 9.8 1.4 16.6 43.8 28.1
IL-15−/− 43.1 ± 13.7 NDe 15.3 57.8 17.0
a Infected with 250.
b Days post-infection.
c Only means are shown.
d Averages of 6 experiments.
e Not detected.
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inflammatory population, remains to be confirmed.
NK cells and γδ T cells both require IL-15 for development
and homeostatic maintenance (Kennedy et al., 2000). IL-15 can
be produced by many cell types, including microglia and
activated astrocytes (Hanisch et al., 1997; Kurowska et al.,
2002; Lee et al., 1996; Li et al., 2004; Maslinska et al., 2002;
Nagai et al., 2001). This pleiotropic factor further supports NK
cell expansion during infection (Lodolce et al., 1998; Nguyen et
al., 2002) and is important for homeostatic maintenance of
memory CD8+ T cells (Becker et al., 2002; Tan et al., 2002).
Induction of IL-15 following mouse hepatitis virus (MHV)
infection of CNS-derived cells (Li et al., 2004) and during
experimental autoimmune encephalitis (Tran et al., 2000)
implies a role of this cytokine in enhancing both innate and
adaptive CNS immune responses. This notion is consistent with
reports suggesting a correlation between increased IL-15
expression and progression of multiple sclerosis (Blanco-Jerez
et al., 2002; Kivisakk et al., 1998; Losy et al., 2002; Pashenkov
et al., 1999), which may reflect pro-inflammatory properties of
IL-15 (Ma et al., 2000).
Based on the role of IL-15 in both innate and adaptive
peripheral immune responses, as well as its potential regulation
of CNS inflammatory disease, the contribution of IL-15 to
JHMV pathogenesis was examined in IL-15−/−mice. IL-15 may
affect CNS inflammation, viral clearance and demyelination
directly or via activities of NK cells, γδ T cells and CD8+ T
cells. Naive IL-15−/− mice have no NK cells and diminished
peripheral CD8+ T cells, especially within the CD122+ (IL-2/15
Rβ chain), CD44+ memory subset (Kennedy et al., 2000).
However, following peripheral infections with lymphocytic
choriomeningitis virus (LCMV), recombinant vaccinia virus
and recombinant Sindbis virus, no defects in CD8+ T cell
expansion were detected (Becker et al., 2002; Zuo et al., 2005).
Furthermore, initial expansion of CD8+ T cells was only
marginally affected following vesicular stomatitis virus infec-
tion (Schluns et al., 2002). Confirming effective CD8+ T cell
function, peripheral infections were all controlled in IL-15−/−
mice with kinetics similar to wild-type (wt) mice (Becker et al.,
2002; Schluns et al., 2002; Zuo et al., 2005). These data
predicted that virus-specific CD8+ T cell expansion should not
be significantly affected following JHMV infection, providing a
model to monitor the influence of NK and γδ T cells during
CNS infection of a relatively immunocompetent host.
The present study demonstrates that IL-15 plays a redundant
role in JHMV pathogenesis and control of virus replication in
the CNS. Although the frequency of virus-specific effector
CD8+ T cells recruited to the CNS was reduced compared to wt
mice, clearance of infectious virus was only slightly delayed.
Despite the absence of NK cells, there was no evidence for
delayed IFNγ-induced MHC expression on CNS resident cells,
suggesting that these effectors do not contribute significantly to
viral clearance or enhanced adaptive immune effector functions
within the CNS. Furthermore, the absence of innate lympho-
cytes and reduced CD8+ T cell numbers did not ameliorate
clinical disease or demyelination. Thus, despite the pleiotropic
role of IL-15 in regulating innate and adaptive immuneresponses (Ma et al., 2000), little evidence was obtained
supporting a role of either NK cells or γδ T cells in JHMV-
induced encephalomyelitis or demyelination in otherwise
immunocompetent hosts.
Results
Inflammation and pathogenesis in the CNS
IL-15−/− mice were infected with JHMV to examine effects
of IL-15 deficiency, associated with absence of NK and γδ T
cells, on CNS inflammation and pathogenesis. The mean day of
onset, extent of clinical disease, morbidity and recovery from
acute JHMV infection of IL-15−/− mice were similar to those of
wt mice (data not shown). To determine how the composition of
bone marrow-derived CD45hi inflammatory cells was altered in
the absence of IL-15, CNS inflammatory cells were character-
ized by flow cytometry. The absence of NK cells and reduced
peripheral CD8+ T lymphocyte subsets in IL-15−/− mice only
slightly diminished the overall numbers of inflammatory cells
recruited into the CNS during acute JHMV infection (Table 1).
NK cells were rapidly recruited into the CNS in wt mice, peaked
at day 5 p.i. and then declined to barely detectable levels by day
14 p.i., in contrast to their absence from the CNS of infected IL-
15−/− mice. Macrophages constituted the vast majority of CNS
infiltrating cells in both groups early following infection,
suggesting IL-15-independent recruitment. Although the per-
centage of macrophages declined as inflammation increased,
they were retained at similar levels in both groups (Table 1). The
absence of IL-15 resulted in diminished CD8+ T cell
recruitment, possibly reflecting the overall reduction in
peripheral CD8+ T cells (Kennedy et al., 2000; Tan et al.,
2002; Zuo et al., 2005). No significant differences in either
percentages or expression levels of activation markers, i.e.,
CD43, CD44 and CD62L, on infiltrating CD8+ T cells were
detected comparing the two groups (data not shown). Although
there was no apparent increase in CD4+ T cells early in
infection, substantially higher percentages of CD4+ T cells were
evident in the CNS of IL-15−/− mice during peak inflammation
(Table 1). Surprisingly, although IL-15 affects the γδ T cell
Fig. 1. Distinct phenotypes and frequencies of JHMV-specific CD8+ T cells in
lymphoid organs and the CNS. (A) JHMV-specific CD8+ T cells in the spleen,
cervical lymph nodes and brain were assessed by Dd/S510 tetramer staining and
flow cytometry at day 7 p.i. The plots are gated on CD8+ T cells. A
representative of 3 independent experiments using mononuclear cells from
pooled animals (n ≥ 3) is shown. The numbers in each quadrant represent
percentages within CD8+ T cells. (B) Absolute numbers of tetramer+ CD8+ T
cells in the brain were obtained based on yields of cell preparations and flow
cytometric analysis at days 7 and 14 p.i. Data are presented as mean ± SEM of 3
independent experiments in which more than 3 mice were used at each time
point per group.
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et al., 2000), γδ T cells constituted between 1.4 and 2.1% of the
inflammatory population at day 5 p.i. in the CNS of wt and IL-
15−/− mice and remained between 0.8 and 2.1% out to day
17 p.i. (data not shown). There was no evidence for decreased
numbers in the CNS of IL-15−/− compared to wt mice at any
single time point, contrasting the NK cell population.
Induction of JHMV-specific CD8+ T cells in lymphoid organs
A considerable proportion of bystander CD8+ T cells,
characterized by a non-activated memory phenotype, are
recruited during CNS JHMV infection (Chen et al., 2005).
The reduced CD8+ T cell percentage in the CNS of infected IL-
15−/− mice thus likely reflects the reduced memory cells in
lymphoid organs (Kennedy et al., 2000; Tan et al., 2002).
Furthermore, expansion of virus-specific CD8+ T cells in IL-
15−/− mice following peripheral infection is not compromised
(Becker et al., 2002; Schluns et al., 2002; Zuo et al., 2005),
consistent with the concept that IL-15 acts primarily to sustain
memory cells (Prlic et al., 2002). To test how IL-15 deficiency
impacts virus-specific CD8+ T cell expansion following an
infection restricted to the CNS, JHMV-specific CD8+ T cells
were compared in the CNS, spleen and CLN, the primary site of
T cell priming following CNS infection (Dorries, 2001; Marten
et al., 2003). The proportions of JHMV spike protein-specific
CD8+ T cells were comparable in spleen and CLN in IL-15−/−
and wt mice at day 7 p.i. (Fig. 1A), supporting IL-15-
independent expansion (Becker et al., 2002; Zuo et al., 2005).
Analysis of the CNS at day 7 p.i. revealed slightly reduced
percentages of tetramer+ cells within the CD8+ Tcell population
derived from the infected IL-15−/− mice. Surprisingly, although
the majority of tetramer+ cells in secondary lymphoid organs
expressed CD122 (IL-2/15Rβ), virus-specific CD8+ T cells
recruited into the CNS were CD122−/dim in both groups (Fig.
1). These data imply either preferential recruitment of the
CD122−/dim population or downregulation of CD122 expres-
sion upon CNS entry. Overall, the relative number of virus-
specific CD8+ T cells within the CNS was reduced 2–3-fold in
the infected IL-15−/− mice compared to wt mice during peak
inflammation at day 7 p.i. (Fig. 1B). Although the CD8+ T cells
in the CNS of wt mice declined as infectious virus and viral
antigen was reduced, the total number of virus-specific CD8+
T cells in the CNS of the IL-15−/− mice remained constant
(Fig. 1B). These data suggest that induction, expansion and
recruitment of virus-specific CD8+ T cells in response to an
infection localized to the CNS are independent of IL-15.
Efficient control of JHMV infection of the CNS
NK cells played a major role in control of a recombinant
MHV expressing CXCL10 in the CNS of RAG1−/− mice
(Trifilo et al., 2004). The absence of NK cells, coupled with
reduced virus-specific CD8+ T cells within the CNS of infected
IL-15−/− mice suggested that control of virus replication may be
defective. Nevertheless, JHMV replication in the CNS of IL-
15−/− mice was not significantly affected at days 3 or 5 p.i. andonly slightly increased at day 7 p.i. compared to wt mice (Fig.
2A). Overall, IL-15−/− mice controlled infectious virus within
the CNS with kinetics very similar to wt mice (Fig. 2). Viral
antigen in the CNS of IL-15−/− and wt mice was compared at
day 7 p.i. (Fig. 2B) to determine if the slight increase in
infectious virus represented altered viral tropism. However, no
difference in either the amount or distribution of viral antigen,
predominantly in astrocytes and oligodendroglia, was detected
when comparing both groups (Fig. 2B). This suggests an
Fig. 2. Control of JHMV replication in the CNS of IL-15−/− mice. (A) Infectious virus within the CNS of JHMV-infected IL-15−/− and wt mice was determined by
plaque assay as described in Materials and methods. The dashed line marks the detection level. Data represent mean ± SD (n ≥ 3/group) and are representative of 3
separate experiments. (B) Distribution of viral antigen in brains of JHMV infected wt (a) and IL-15−/−mice (b) determined at day 7 p.i. by immunoperoxidase staining
using anti-JHMV mAb J.3.3. Antigen positive cells are demonstrated by the presence of chromogen aminoethylcarbzole (arrows). Sections counterstained with
hematoxylin. The pattern and extent of antigen staining were similar in wt and IL-15−/− mice. Scale bar = 100 μm.
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CD8+ T cell response to mediate virus control in the CNS in the
absence of IL-15.
IL-15-independent MHC expression on microglia
In the quiescent CNS, resident glial cells express few if any
MHC molecules. However, pro-inflammatory cytokines, in-
cluding interferons and TNF, induce increased expression of
MHC molecules in the CNS during inflammation (Bergmann et
al., 2003; Liu and Lane, 2001; Zhou et al., 2005b). JHMV
infection induces MHC class I molecules on microglia,
independent of IFNγ; however, expression of MHC class II
molecules depends exclusively on IFNγ (Bergmann et al.,
2003). Although NK cells appeared to play no direct role in
viral clearance, they may nevertheless enhance early MHC
molecule expression on glial cells via IFNγ secretion and thus
optimize αβ Tcell effector function. To evaluate a potential role
of NK cells in enhancing antigen presentation capacity, the
kinetics of MHC class I and II upregulation were assessed on
microglia (Fig. 3). Class I molecule expression emerged as early
as day 3 p.i. in both IL-15−/− and wt mice (Fig. 3A). Although
microglia derived from infected IL-15−/− expressed less class Imolecules at day 5 p.i., expression was maximal on microglia in
both groups of mice by day 7 p.i. In contrast to class I
expression, class II molecules remained below detection on
microglia from either group at day 3 p.i. and only increased
slightly by day 5 p.i. This delay in class II expression, relative to
class I, was overcome at day 7 p.i. when ∼90% of microglia
derived from both groups of JHMV-infected mice expressed
MHC class II molecules (Fig. 3B). The absence of an evident
difference in MHC molecule upregulation suggests little, if any,
contribution of innate lymphocytes to IFNγ secretion early
during infection. Maximal MHC molecule expression coinci-
dent with peak CNS T cell numbers underscores the critical role
of αβ T cells as a source of IFNγ in regulating both class I and
class II molecule expression on CNS resident cells.
JHMV-specific CD8+ T cell responses in the CNS
CNS infiltrating CD8+ T cells in both IL-15−/− and wt mice
were CD44hi, CD62Llo/−, expressed similar levels of CD43, and
were CD127− (data not shown), a pattern associated with
effector function (Kaech et al., 2003; Onami et al., 2002).
Furthermore, the majority of CNS CD8+ T cells in both groups
apparently downregulated CD122 expression (Fig. 1A),
Fig. 3. MHC expression on microglia. Expression of MHC class I (A) and MHC class II (B) on CD45lo microglia derived from infected IL-15−/− and wt mice at
indicated time points. Shaded areas represent histograms of control isotype antibodies. Solid lines and dashed lines represent histograms of wt mice and IL-15−/−mice,
respectively. Representative of 5 separate experiments.
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binding. CNS CD8+ T cell functions were evaluated to support
phenotypic similarities observed in both groups. Virus-specific
IFNγ production was detected in ∼20% of infiltrating CD8+ T
cells in both IL-15−/− and wt mice at day 7 p.i. (Fig. 4A).
Consistent with the slight reduction in CD8+ T cells infiltrating
the CNS of the infected IL-15−/− mice, CNS mononuclear cells
from IL-15−/− mice expressed reduced ex vivo cytolytic activityFig. 4. Effector function expression by CNS-derived virus-specific CD8+ T cells. (A
infected wt and IL-15−/−mice at day 7 p.i. Percentages of IFNγ+ CD8+ T cells (inside
cytolytic activity mediated by CNS-derived CD8+ T cells from wt and IL-15−/− mic
Frequencies of virus-specific CD8+ T cells in CNS-derived mononuclear cells were de
CD8+ T cells are shown. Representative of 3 independent experiments.compared to wt mice at the population level (Fig. 4B).
However, adjustment to cytolysis per tetramer+ CD8+ T cell
revealed no differences in lytic capacity between cells from the
CNS of IL-15−/− and wt mice (Fig. 4B). Therefore, despite
decreased CD8+ T cell numbers within the CNS in the absence
of IL-15, differentiation to anti-viral effector T cells, based on
both the ability to secrete IFNγ and express cytolytic activity,
was not affected. Similar kinetics of class I expression (Fig. 3)) Frequency of virus-specific IFNγ-secreting CD8+ T cells within the CNS of
rectangles) within infiltrating CD8+ Tcells are shown. (B) Ex vivo virus-specific
e at day 7 p.i. Cytolysis was measured as described in Materials and methods.
termined by tetramer-staining and flow cytometry. E:T ratios based on tetramer+
Fig. 5. IFNγ within the CNS of IL-15−/− and wt mice. (A) CNS IFNγ was
assessed by ELISA at various times p.i. in infected wt and IL-15−/− mice. Data
represent mean ± SEM of individual mice (n ≥ 3). (B) Frequencies of virus-
specific IFNγ secreting CD4+ T cells (inside rectangles) within the CNS of
JHMV-infected wt and IL-15−/− mice at day 7 p.i. CNS-derived mononuclear
cells from pooled animals (n ≥ 3) were stimulated with or without peptide for 6
h and then stained for intracellular IFNγ. Plots are gated on infiltrating CD4+ T
cells and percentages of IFNγ+ CD4+ T cells within CD4+ T cells are shown.
Representative of 3 independent experiments.
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IFNγ secretion at day 5 p.i. as only few class II expressing cells
are available to trigger IFNγ secretion by CD4+ T cells.Fig. 6. Inflammation and demyelination in the CNS of JHMV-infected wt and IL-15−
(A) and IL-15−/− (B) mice at day 14 p.i. by Luxol fast blue staining. Size and distribu
cell infiltration are similar in both groups. Scale bar = 100 μm.Potent IFNγ production within the CNS in the absence of IL-15
IFNγ is crucial for the control of JHMV in the CNS, as it
enhances both CD4+ and CD8+ T cell function by increasing
MHC molecule expression on target cells (Bergmann et al.,
2003, 2004). It is furthermore vital for viral clearance from
oligodendrocytes (Bergmann et al., 2004; Parra et al., 1999).
Similar patterns of MHC expression on microglia suggested
comparable IFNγ production in both groups, despite the
absence of NK cells and reduced virus-specific CD8+ T cells
within the inflamed CNS (Table 1; Fig. 1). Therefore, CNS
IFNγ levels were measured to test whether MHC upregulation
was saturated, thus under representing in vivo IFNγ levels.
IFNγ was already present in the CNS of both groups at day 5 p.
i., increased sharply at day 7 p.i., coincident with the peak of T
cell responses (Table 1), and rapidly declined at day 10 p.i. (Fig.
5A). These data suggest a downregulation of IFNγ secretion
within the CNS as both infectious virus and viral antigen are
cleared, even though both CD4+ and CD8+ T cells were still
abundant (Table 1). The slight over-representation of CD4+ T
cells within the CNS inflammatory population in IL-15−/− mice
suggested the possibility that this population may compensate
for decreased CD8+ T cells. This interpretation is supported by
the ability of nearly equivalent frequencies (∼20%) of CNS-
derived virus-specific CD4+ T cells to secrete IFNγ (Fig. 5B).
These data suggest that neither the absence of IL-15 nor
absence of NK cells affects virus clearance from the CNS.
Although NK cells have not directly been implicated in the
process of myelin loss following JHMV infection, recent data
suggested that γδ T cells influence JHMV-induced demyelin-
ation (Dandekar et al., 2005; Dandekar and Perlman, 2002). To
examine the possibility that IL-15 deficiency influenced the loss
of myelin in a relatively immunocompetent host, demyelination
was compared in infected IL-15−/− and wt mice. Focal areas of
demyelination were present in the brains and spinal cords of
both groups at day 10 p.i. (data not shown). Consistent with
previous data (Wang et al., 1990), the extent of spinal cord
demyelination increased with time p.i. in both groups. Although
focal areas of myelin loss and inflammation were evident in the
spinal cords of both groups (Fig. 6), no differences in the extent
or distribution of inflammatory cells or demyelinated lesions/− mice. Extent of demyelination and inflammation in spinal cords of infected wt
tion of plaques of demyelination (outlined by arrows) and extent of mononuclear
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extent or distribution of F4/80+ macrophages, CD4+ or CD8+ T
cells were detected comparing the CNS of infected IL-15−/− and
wt mice (data not shown). These data suggest that neither the
absence of IL-15 nor absence of NK cells influences myelin loss
following JHMV infection of otherwise immunocompetent
hosts.
Discussion
IL-15 is an important pleiotropic cytokine crucial for NK cell
development and homeostatic maintenance of memory CD8+ T
cells (Kennedy et al., 2000; Ma et al., 2000; Prlic et al., 2002).
Despite the profound defect in these cell populations, IL-15−/−
mice mount effective virus-specific CD8+ T cell responses and
control numerous experimental peripheral viral infections
(Becker et al., 2002; Obar et al., 2004; Schluns et al., 2002;
Zuo et al., 2005). An exception is the increased mortality
following neurovirulent vaccinia virus infection (Kennedy et
al., 2000). This report is the first to demonstrate that IL-15 is not
required to control a coronavirus infection, confined to the CNS
and dependent on CD8+ T cell responses for anti-viral control
(Bergmann et al., 2003; Marten et al., 2001).
JHMV infection is restricted to the brain and spinal cord and
results in the recruitment of multiple innate and adaptive effector
cells, including both NK and CD8+ T cells (Marten et al., 2001).
Several observations suggested that NK cell activity may be
important in early control of JHMV, possibly prior to induction
of adaptive immunity. Among these are the slight reduction in
virus replication in SCID mice (Houtman et al., 1995) and the
apparent partial control of infectious virus in the CNS of mice
deficient in either CD4+ or CD8+ T cells (Williamson and
Stohlman, 1990). Early control of a less neurovirulent MHV-
A59 strain engineered to express CXCL10 in RAG1−/− mice
also supports NK cell-mediated anti-viral function (Trifilo et al.,
2004). By contrast, analysis of NK deficient IL-15−/−mice failed
to detect any evidence for delayed or reduced IFNγ production
or other anti-viral activity following JHMV infection. Both
direct analysis of IFNγ and indirect analysis via MHC class II
upregulation on microglia revealed no differences during the
time of maximal NK cell recruitment. The notion that NK cells
do not exert detectable effector function within the inflamed
CNS in immunocompetent hosts was further supported by the
inability to detect NK cytolytic activity in splenocytes of
infected wt mice (data not shown). The discrepancy between the
apparently redundant role of NK cells in immunocompetent
mice and the data obtained in RAG1−/−mice (Trifilo et al., 2004)
may reside in themore rapid and increasedNK cell inflammation
achieved by over-expression of CXCL10.
The absence of IL-15 did not affect virus-specific CD8+ Tcell
expansion, CNS recruitment or differentiation into antigen-
specific effector cells. Rapid activation of CD8+ Tcells was also
evident following peripheral JHMV infection (unpublished
data). Induction and expansion of T cells in response to CNS
infection occur in secondary lymphoid organs (Dorries, 2001;
Marten et al., 2003). Consistent with signaling through the IL-2/
15Rβ chain CD122 during the expansion phase, possible via IL-2, the majority of JHMV-specific CD8+ T cells in the spleen and
CLN expressed CD122 in both IL-15−/− and wt mice.
Interestingly, the vast majority of CD8+ T cells recruited into
the CNS in the brain were CD122−. CD122 expression is thus
either downregulated after CD8+ T cells enter the CNS, or
alternatively, the CD122−/lo population preferentially traffics
into the CNS. The first explanation is favored by the low
frequency of CD122−/lo virus-specific CD8+ Tcells in lymphoid
organs as well as the downregulation of CD122 on splenic CD8+
T cells after 6 h in vitro stimulation with peptide (data not
shown). Whether CD122 is downregulated as a result of
abundant Ag stimulation or withdrawal of CD122 ligands,
e.g., IL-2, is presently unclear. However, the dispensability of
CD122 of CNS localized Tcells is consistent with the notion that
T cell expansion is inhibited following entry into infected non-
lymphoid parenchymal tissues. In the CNS, T cell expansion
appears to be inhibited by prostaglandins and other down-
regulatory factors (Irani and Griffin, 2001). However, recent
evidence from the Theiler's murine encephalitis virus model
disputes this notion by demonstrating de novo priming and
proliferation of auto-reactive TCR transgenic T cells within the
CNS (McMahon et al., 2005). Irrespectively, the apparent
survival of CD122−/lo polyclonal CD8+ T cells in the CNS is
consistent with the absence of an adverse effect of IL-2
inhibition during JHMV infection of the CNS (Zhou et al.,
2005a).
Reduced absolute numbers of virus-specific CD8+ T cells
recruited into the CNS of IL-15−/− mice compared to wt mice
likely reflect the overall reduced peripheral CD8+ T cell
population in naive IL-15−/− mice. The small, but reproducible,
increase in infectious virus in the CNS of the IL-15−/− mice at
day 7 p.i. may thus reflect the overall reduction in the CNS
infiltrating CD8+ T cells. Nevertheless, IL-15−/− mice con-
trolled JHMV replication with kinetics similar to wt mice,
disputing an overall defect in anti-viral activity. JHMV
clearance from the CNS in wt mice is dependent upon both
perforin-mediated cytolysis and IFNγ secretion (Bergmann et
al., 2004; Lin et al., 1997; Parra et al., 1999). Direct
measurement of IFNγ showed comparable amounts of IFNγ
suggesting that virus-specific CD4+ T cells may compensate for
reduced CD8+ T cells in IL-15−/− mice. Although a consider-
able fraction of IL-15−/− CD4+ Tcells produced IFNγ following
Ag stimulation, no evidence for altered virus tropism or
enhanced MHC class II expressing macrophages/microglia
was detected. Overall, this finding underscores flexibility of T
cell responses and a synergy between CD4+ and CD8+ T cells in
controlling CNS viral infections.
IL-15 and γδ T cells have been implicated in regulating the
process of myelin loss (Blanco-Jerez et al., 2002; Dandekar et
al., 2005; Dandekar and Perlman, 2002; Kivisakk et al., 1998;
Losy et al., 2002; Pashenkov et al., 1999). However, no
differences in the extent or distribution of demyelinated lesions
were found in either brains or spinal cords of infected IL-15−/−
mice compared to wt mice. Although the gastrointestinal tract of
IL-15−/− mice is deficient in γδ T cells (Kennedy et al., 2000), it
was surprising to detect similar, albeit small numbers of γδ T
cells in the CNS of both wt and IL-15−/−-infected mice
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between the groups could be detected in these small populations
at any given time point. Therefore, the analysis of JHMV
pathogenesis in IL-15−/− was unable to shed light on the
potential role of this T cell subset, implicated in JHMV induced
demyelination in nude mice (Dandekar et al., 2005; Dandekar
and Perlman, 2002). In conclusion, our data demonstrate that
IL-15 is not essential for effective anti-viral immunity against a
neurotropic coronavirus infection. Although NK cells are
recruited into the infected CNS, no evidence could be found
to support either direct anti-viral effector functions or indirect
function mediated via enhanced adaptive immunity. Both IL-15
and NK cells are thus dispensable for inflammation, demyelin-
ation and pathogenesis in the CNS. These data underscore the
importance of adaptive immune responses during JHMV
infection of the CNS.
Materials and methods
Mice and infection
Homozygous C57BL/6 IL-15−/− (IL-15−/−) mice (Kennedy
et al., 2000), originally provided by Amgen Corporation
(Seattle, WA), were bred locally. Syngeneic C57BL/6 mice
were purchased from the National Cancer Institute (Frederick,
MD) at 5–6 weeks of age. Mice were housed in an accredited
animal facility at the University of Southern California and were
used between 6 and 8 weeks of age. All procedures were
performed in compliance with protocols approved by the Keck
School of Medicine Institutional Animal Care and Use
Committee. For each experiment, mice were both sex- and
age-matched, and groups of at least 3 individuals were analyzed
per time point. No gender-dependent differences were observed.
Infections were initiated by intracerebral injection of 250 PFU
of the J.2.2v-1 monoclonal antibody (mAb) neutralization-
derived JHMV variant as previously described (Fleming et al.,
1986). Infected mice were scored for clinical symptoms daily as
previously described (Lin et al., 1997).
Virus titers and IFNγ ELISA
Infectious JHMV within the CNS was determined in
clarified supernatants derived from homogenates of one-half
brain by plaque assay on monolayers of DBT cells as previously
described (Lin et al., 1997). Plaques were counted after 48
h incubation at 37 °C. Supernatants were also tested for IFNγ
by ELISA. Briefly, 96 well plates (Dynex Technologies,
Chantilly, VA) were coated for 18 h at 4 °C with 100 μl
containing 1.5 μg/ml of anti-IFNγ (R4-6A2). Non-specific
binding was blocked with PBS containing 10% FCS. Samples
and recombinant cytokines (BD PharMingen) were adsorbed
overnight 4 °C. Color was developed by sequential addition of
biotinylated detection anti-IFNγ (XMG1.2) followed by avidin
peroxidase and hydrogen peroxide (TMB Substrate Reagent A,
BD PharMingen) and 3,3′,5,5′ Tetramethylbenzidine (TMB
Substrate Reagent B) 30 min later. Color was developed for 15
min and results read at 405 nm using a Bio-Rad Model 680microplate reader and analyzed using Microplate Manager 5.2
software (Bio-Rad Laboratories, Hercules, CA).
Mononuclear cell preparations
CNS mononuclear cells were isolated at various time points
post-infection (p.i.) from brains or spinal cords (SC) of 3–6
mice per group, as previously described (Bergmann et al., 2003;
Marten et al., 2000). Briefly, tissues were homogenized in ice-
cold Tenbrock homogenizers, adjusted to 30% Percoll (Phar-
macia, Uppsala, Sweden) and suspensions layered onto a 1 ml
70% Percoll cushion. Following centrifugation at 800×g for 25
min at 4 °C, cells were recovered from the 30%/70% Percoll
interface and resuspended in RPMI medium. Single cell
suspensions were prepared from RBC-depleted spleens or
cervical lymph nodes (CLN) as previously described (Marten et
al., 2000).
Flow cytometric analysis
Expression of cell surface markers was determined as
described previously (Zuo et al., 2005). Briefly, non-specific
antibody binding was inhibited by incubation with anti-mouse
CD16/CD32 (2.4G2, BD PharMingen) for 15 min at 4 °C prior
to staining. For flow cytometric analysis, cells were stained with
FITC-, PE- or CyChrome-conjugated mAb (for 3 color
analysis), or FITC-, PE-, Percp- or APC-conjugated mAb (for
4 color analysis) for 30 min at 4 °C in PBS containing 0.1%
BSA using mAb specific for CD8 (53–6.7), CD4 (GK1.5),
NK1.1 (PK136), γδ TCR (GL3), CD43 (1B11), CD44 (IM7),
CD45(30–F11), CD62L(MEL-14), CD122 (TM-β1) (all from
BD PharMingen), CD127(A7R34, eBioscience, San Diego,
CA) and F4/80 (A3-1, Serotech, Raleigh, NC). Virus-specific
CD8+ T cells were detected with PE labeled Db-S510 class I
tetramer as previously described (Zuo et al., 2005). Stained cells
were fixed with 2% paraformaldehyde and analyzed on a
FACSCalibur flow cytometer (Becton Dickinson, Mountain
View, CA). Forward and side scatter signals obtained in linear
mode were used to establish a gate containing live lymphocytes.
A minimum of 2.5 × 105 viable cells were stained and 0.5–
2 × 105 events per sample analyzed using CellQuestPro
software (Becton Dickinson). Intracellular staining for IFNγ
was performed as described previously (Zuo et al., 2005).
Briefly, 1 × 106 CNS mononuclear cells were stimulated in 200
μl of RPMI 1640 supplemented with 10% FCS, containing 1
μM S510 peptide (CSLWNGPHL) (Zuo et al., 2005) for CD8+
T cells or the I-Ab-restricted M133 peptide (TVYVRPIIE-
DYHTLT) (Haring et al., 2001) presented by CHB3 cells (I-Ab)
(Bishop et al., 1993) for CD4+ T cells and 1 μl/ml Golgistop
(BD PharMingen) for 6 h. Peptides were synthesized by the
University of Southern California Norris Cancer Center
Microchemistry Laboratory and purity assessed by HPLC and
mass spectrometry. CHB3 cells (I-Ab) were derived from a B-
cell tumor (Bishop et al., 1993) and used at a ratio of 5 CHB3
cells to 1 lymphocyte (Haring et al., 2001). Cells were surface-
stained with anti-CD8 or CD4 mAbs, fixed and permeabilized
with cytofix/cytoperm reagents, and finally stained with anti-
214 J. Zuo et al. / Virology 350 (2006) 206–215IFNγ mAb (XMG1.2) according to the suppliers' instructions
(BD PharMingen).
Ex vivo cytolysis
CNS mononuclear cells were evaluated for CD8+ T cell-
mediated ex vivo cytolytic activity at the indicated time points
p.i. as previously described (Zuo et al., 2005). Briefly,
Na51CrO4-labeled EL-4 (H-2
b) target cells were coated with
S510 peptide at 1 μM prior to addition of the CNS mononuclear
cells at various Effector:Target (E:T) ratios. 51Cr release was
determined in 100 μl of supernatant following 4 h incubation at
37 °C. Specific lysis is defined as 100 × (experimental release-
spontaneous release)/(maximal release-spontaneous release).
Spontaneous release values were b10% of detergent release.
Histopathology
Brains, bisected in the mid-coronal plane, and spinal cords
were examined for inflammation, demyelination and viral Ag as
previously described (Lin et al., 1997). Briefly, tissues were
fixed for 3 h in Clark's solution (75% ethanol and 25% glacial
acetic acid) before paraffin embedding. Deparaffinized sections
were stained with hemotoxylin and eosin to determine
inflammation or luxol fast blue for demyelination. Distribution
of viral Ag was determined by immunoperoxidase staining
(Vectastain-ABC kit; Vector Laboratories, Burlingame, CA)
using the anti-JHMV mAb J.3.3 specific for the carboxyl
terminus of the viral nucleocapsid protein as primary Ab and
horse anti-mouse secondary Ab (Vector Laboratories). Sections
were scored for inflammation, demyelination and viral Ag in a
blinded fashion. Representative fields were identified based on
average scores for all sections in each experimental group.
Statistical analysis
Means from 2 groups of mice were compared by two-tailed
Student's t test and a difference was statistically significant
when P value is b0.05.
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